Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Avista Healthcare Public Acquisition Corp. to combine with Organogenesis Inc.

Published 08/17/2018, 05:14 PM
Updated 08/17/2018, 05:14 PM
© Reuters.  Avista Healthcare Public Acquisition Corp. to combine with Organogenesis Inc.
  • Avista Healthcare Public Acquisition Corp. (AHPA -0.2%) and Organogenesis Inc. announced that they have entered into a definitive merger agreement, under which Organogenesis will become a wholly owned subsidiary of AHPAC.
  • Following the closing of the transaction, Organogenesis will be listed on the Nasdaq Stock Exchange under the ticker symbol "ORGO."
  • The combined company will have an anticipated initial enterprise value of ~$673M.
  • This transaction will be funded through a combination of cash, stock, and rollover debt financing.
  • Credit Suisse (SIX:CSGN) Securities (NYSE:USA) LLC is acting as financial advisor to AHPAC.
  • Weil, Gotshal & Manges LLP is acting as legal advisor to AHPAC.
  • Foley Hoag LLP is acting as legal advisor to Organogenesis.
  • Now read: Technically Speaking: 'It Can Only Go Up From Here'


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.